Compound ID | 2082
Class: Sulfonamide
| Agent Type: | Synthetic; Small molecule; Indirect acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Anti-inflammatory action |
| Description: | Synthetic sufanilamide derivative. Prodrug with active metabolites 5-aminosalicylic acid and sulfapyridine. Oral use as antiinflammatory drug for ulcerative colitis, Crohn's disease and rheumatoid arthritis. |
| Year first mentioned: | 1959 |
| Highest development stage: | Approved for other indications |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5339 |
| Guide to Pharmacology: | sulfasalazine |
| Citation: | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/007073s124lbl.pdf |